10-K Filing

MANHATTAN BRIDGE CAPITAL, INC CIK: 1080340 FY 2016

Filing Information

Form Type	10-K
Accession Number	`0001493152-17-002439`
Period End Date	20161231
Filing Date	20170315
Fiscal Year	2016
Fiscal Period	FY
XBRL Instance	loan-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 36 Cash Flow Statement 61 Stockholders Equity 23

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Debt Issuance Costs, Net (deferred financing costs)	`DeferredFinanceCostsNet`	$697.67K	USD	Point-in-time
Debt Issuance Costs, Net (deferred financing costs)	`DeferredFinanceCostsNet`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.84K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$96.30K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$47.68K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Short term loans receivable	`NotesAndLoansReceivableGrossCurrent`	$20.20M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Short term loans receivable	`NotesAndLoansReceivableGrossCurrent`	$27.50M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Interest receivable on loans	`InterestReceivableCurrent`	$382.57K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Interest receivable on loans	`InterestReceivableCurrent`	$346.52K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$29.40K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$32.87K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	25.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	25.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.44M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$20.72M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.31M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$27.97M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.26M	shares	Point-in-time
Long term loans receivable	`NotesAndLoansReceivableGrossNoncurrent`	$10.71M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.14M	shares	Point-in-time
Long term loans receivable	`NotesAndLoansReceivableGrossNoncurrent`	$7.26M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.98K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.77K	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	177,000.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	177,000.00	shares	Point-in-time
Security deposit	`SecurityDeposit`	$6.82K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$6.82K	USD	Point-in-time
Investment in privately held company	`CostMethodInvestments`	$50.00K	USD	Point-in-time
Investment in privately held company	`CostMethodInvestments`	$35.00K	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$56.19K	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$164.51K	USD	Point-in-time
Total assets	`Assets`	$35.33M	USD	Point-in-time
Total assets	`Assets`	$31.66M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$6.48M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$11.82M	USD	Point-in-time
Short term loans	`ShortTermBorrowings`	$1.10M	USD	Point-in-time
Short term loans	`ShortTermBorrowings`	-	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$105.54K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$99.64K	USD	Point-in-time
Deferred origination fees	`DeferredOriginationFees`	$315.41K	USD	Point-in-time
Deferred origination fees	`DeferredOriginationFees`	$279.68K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$813.50K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$617.44K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.72M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.91M	USD	Point-in-time
Senior secured notes (net of deferred financing costs of $697,669)	`SecuredLongTermDebt`	$5.30M	USD	Point-in-time
Senior secured notes (net of deferred financing costs of $697,669)	`SecuredLongTermDebt`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$13.91M	USD	Point-in-time
Total liabilities	`Liabilities`	$13.02M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares - $.01 par value; 5,000,000 shares authorized; no shares issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares - $.01 par value; 5,000,000 shares authorized; no shares issued	`PreferredStockValue`	-	USD	Point-in-time
Common shares - $.001 par value; 25,000,000 authorized; 8,312,036 and 7,441,039 issued; 8,135,036 and 7,264,039 outstanding	`CommonStockValue`	$7.44K	USD	Point-in-time
Common shares - $.001 par value; 25,000,000 authorized; 8,312,036 and 7,441,039 issued; 8,135,036 and 7,264,039 outstanding	`CommonStockValue`	$8.31K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$23.13M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$18.50M	USD	Point-in-time
Treasury stock, at cost - 177,000	`TreasuryStockValue`	$369.33K	USD	Point-in-time
Treasury stock, at cost - 177,000	`TreasuryStockValue`	$369.33K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-395.71K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-459.10K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.74M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$22.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.87M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$35.33M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$31.66M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Interest income from loans	`InterestIncomeFromLoans`	$3.36M	USD	Annual
Interest income from loans	`InterestIncomeFromLoans`	$3.85M	USD	Annual
Origination fees	`OriginationFees`	$803.47K	USD	Annual
Origination fees	`OriginationFees`	$644.71K	USD	Annual
Total Revenue	`Revenues`	$4.00M	USD	Annual
Total Revenue	`Revenues`	$4.65M	USD	Annual
Interest and amortization of deferred financing costs	`InterestAndAmortizationOfDebtServiceCosts`	$691.39K	USD	Annual
Interest and amortization of deferred financing costs	`InterestAndAmortizationOfDebtServiceCosts`	$780.12K	USD	Annual
Referral fees	`ReferralFees`	$2.36K	USD	Annual
Referral fees	`ReferralFees`	$8.68K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.04M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.01M	USD	Annual
Total operating costs and expenses	`OperatingCostsAndExpenses`	$1.79M	USD	Annual
Total operating costs and expenses	`OperatingCostsAndExpenses`	$1.73M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$2.85M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$2.27M	USD	Annual
Impairment loss on property and equipment (Note 5)	`ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss`	-	USD	Annual
Impairment loss on property and equipment (Note 5)	`ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss`	$13.86K	USD	Annual
Loss on write-down of investment in privately held company (Note 6)	`CostmethodInvestmentsOtherThanTemporaryImpairment`	$15.00K	USD	Annual
Loss on write-down of investment in privately held company (Note 6)	`CostmethodInvestmentsOtherThanTemporaryImpairment`	$15.00K	USD	Annual
Total other loss	`NonoperatingIncomeExpense`	$-15.00K	USD	Annual
Total other loss	`NonoperatingIncomeExpense`	$-28.86K	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.84M	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.24M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$2.15K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$1.59K	USD	Annual
Net income	`NetIncomeLoss`	$2.24M	USD	Annual
Net income	`NetIncomeLoss`	$2.84M	USD	Annual
--Basic	`EarningsPerShareBasic`	$0.37	USD	Annual
--Basic	`EarningsPerShareBasic`	$0.33	USD	Annual
--Diluted	`EarningsPerShareDiluted`	$0.33	USD	Annual
--Diluted	`EarningsPerShareDiluted`	$0.37	USD	Annual
--Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	6.76M	shares	Annual
--Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	7.59M	shares	Annual
--Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.61M	shares	Annual
--Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	6.79M	shares	Annual

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net Income	`NetIncomeLoss`	$2.24M	USD	Annual
Net Income	`NetIncomeLoss`	$2.84M	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$39.54K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$101.35K	USD	Annual
Depreciation	`Depreciation`	$3.81K	USD	Annual
Depreciation	`Depreciation`	$5.71K	USD	Annual
Non cash compensation expense	`ShareBasedCompensation`	$13.59K	USD	Annual
Non cash compensation expense	`ShareBasedCompensation`	$13.66K	USD	Annual
Impairment loss on property and equipment (Note 5)	`ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss`	-	USD	Annual
Impairment loss on property and equipment (Note 5)	`ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss`	$13.86K	USD	Annual
Loss on write-down of investment in privately held company (Note 6)	`CostmethodInvestmentsOtherThanTemporaryImpairment`	$15.00K	USD	Annual
Loss on write-down of investment in privately held company (Note 6)	`CostmethodInvestmentsOtherThanTemporaryImpairment`	$15.00K	USD	Annual
Interest receivable on loans	`IncreaseDecreaseInAccruedInterestReceivableNet`	$-36.05K	USD	Annual
Interest receivable on loans	`IncreaseDecreaseInAccruedInterestReceivableNet`	$168.81K	USD	Annual
Other current and non current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-3.47K	USD	Annual
Other current and non current assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.87K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-63.98K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$5.90K	USD	Annual
Deferred origination fees	`IncreaseDecreaseInDeferredOriginationFees`	$-35.73K	USD	Annual
Deferred origination fees	`IncreaseDecreaseInDeferredOriginationFees`	$-34.91K	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.05M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.12M	USD	Annual
Issuance of short term loans	`IssuanceOfShortTermLoans`	$21.61M	USD	Annual
Issuance of short term loans	`IssuanceOfShortTermLoans`	$36.66M	USD	Annual
Collections received from loans	`ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment`	$32.81M	USD	Annual
Collections received from loans	`ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment`	$14.74M	USD	Annual
Purchase of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.26K	USD	Annual
Purchase of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.02K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.88M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.85M	USD	Annual
(Repayments of) proceeds from lines of credit, net	`ProceedsFromRepaymentsOfLinesOfCredit`	$4.12M	USD	Annual
(Repayments of) proceeds from lines of credit, net	`ProceedsFromRepaymentsOfLinesOfCredit`	$-5.34M	USD	Annual
Repayments of loans, net	`RepaymentsOfDebt`	$1.10M	USD	Annual
Repayments of loans, net	`RepaymentsOfDebt`	$1.37M	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$134.66K	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$409.79K	USD	Annual
Proceeds from public stock offering, net	`ProceedsFromIssuanceInitialPublicOffering`	$4.24M	USD	Annual
Proceeds from public stock offering, net	`ProceedsFromIssuanceInitialPublicOffering`	$4.21M	USD	Annual
Proceeds from public stock offering, net	`ProceedsFromIssuanceInitialPublicOffering`	$5.20M	USD	Point-in-time
Proceeds from public bond offering, net	`ProceedsFromPublicBondOfferingNet`	-	USD	Annual
Proceeds from public bond offering, net	`ProceedsFromPublicBondOfferingNet`	$5.31M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.13M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.70M	USD	Annual
Deferred financing costs incurred	`PaymentsOfFinancingCosts`	-	USD	Annual
Deferred financing costs incurred	`PaymentsOfFinancingCosts`	$171.55K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.82M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$791.90K	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$59.16K	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-10.54K	USD	Annual
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$106.84K	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$96.30K	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$47.68K	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$106.84K	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$96.30K	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$47.68K	USD	Point-in-time
Taxes paid during the year	`IncomeTaxesPaidNet`	$56.00	USD	Annual
Taxes paid during the year	`IncomeTaxesPaidNet`	$1.95K	USD	Annual
Interest paid during the year	`InterestPaid`	$596.19K	USD	Annual
Interest paid during the year	`InterestPaid`	$691.58K	USD	Annual
Dividend declared and payable	`DividendDeclaredAndPayable`	$813.50K	USD	Annual
Dividend declared and payable	`DividendDeclaredAndPayable`	$617.44K	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$17.74M	USD	Point-in-time
Balance	`StockholdersEquity`	$22.31M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.87M	USD	Point-in-time
Non cash compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$13.59K	USD	Annual
Non cash compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$13.66K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$61.19K	USD	Annual
Exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-40,000.00	shares	Annual
Exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$73.47K	USD	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$409.79K	USD	Annual
Public offering	`StockIssuedDuringPeriodValueNewIssues`	$4.24M	USD	Annual
Public offering	`StockIssuedDuringPeriodValueNewIssues`	$4.21M	USD	Annual
Public offering	`StockIssuedDuringPeriodValueNewIssues`	$4.46M	USD	Point-in-time
Public offering, shares	`StockIssuedDuringPeriodSharesNewIssues`	1.01M	shares	Point-in-time
Dividends paid	`Dividends`	$-2.09M	USD	Annual
Dividends paid	`Dividends`	$-2.13M	USD	Annual
Dividends declared and payable	`DividendsCash`	$-617.44K	USD	Annual
Dividends declared and payable	`DividendsCash`	$-813.50K	USD	Annual
Net income for the year ended	`NetIncomeLoss`	$2.24M	USD	Annual
Net income for the year ended	`NetIncomeLoss`	$2.84M	USD	Annual
Balance	`StockholdersEquity`	$17.74M	USD	Point-in-time
Balance	`StockholdersEquity`	$22.31M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.87M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.